W. Ru

发表

A phase III clinical trial to evaluate the safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPV23) in healthy children, adults, and elderly

J. Xia, Q. Ye, Jing Li, 2018, Human vaccines & immunotherapeutics.